Vaxcyte Inc [NASDAQ: PCVX] stock went on a downward path that fall over -45.64% on Monday, amounting to a one-week price decrease of less than -48.85%.
Over the last 12 months, PCVX stock dropped by -44.88%. The one-year Vaxcyte Inc stock forecast points to a potential upside of 73.49. The average equity rating for PCVX stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $4.86 billion, with 128.76 million shares outstanding and 125.07 million shares in the current float. Compared to the average trading volume of 1.13M shares, PCVX stock reached a trading volume of 13992582 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Vaxcyte Inc [PCVX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PCVX shares is $142.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PCVX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Vaxcyte Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 20, 2024. While these analysts kept the previous recommendation, Mizuho raised their target price to Buy. The new note on the price target was released on December 07, 2023, representing the official price target for Vaxcyte Inc stock. On January 03, 2023, analysts increased their price target for PCVX shares from 52 to 58.
The Average True Range (ATR) for Vaxcyte Inc is set at 5.93 The Price to Book ratio for the last quarter was 1.43, with the Price to Cash per share for the same quarter was set at 13.57.
PCVX Stock Performance Analysis:
Vaxcyte Inc [PCVX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -48.85. With this latest performance, PCVX shares dropped by -48.29% in over the last four-week period, additionally sinking by -66.12% over the last 6 months – not to mention a drop of -44.88% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PCVX stock in for the last two-week period is set at 15.46, with the RSI for the last a single of trading hit 10.71, and the three-weeks RSI is set at 19.80 for Vaxcyte Inc [PCVX]. The present Moving Average for the last 50 days of trading for this stock 79.14, while it was recorded at 63.69 for the last single week of trading, and 89.06 for the last 200 days.
Insight into Vaxcyte Inc Fundamentals:
Vaxcyte Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 12.75 and a Current Ratio set at 12.75.
PCVX Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PCVX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Vaxcyte Inc go to -5.58%.
Vaxcyte Inc [PCVX] Institutonal Ownership Details
There are presently around $111.79%, or 112.36%% of PCVX stock, in the hands of institutional investors. The top three institutional holders of PCVX stocks are: FMR LLC with ownership of 16.17 million shares, which is approximately 13.788%. BLACKROCK INC., holding 9.94 million shares of the stock with an approximate value of $$750.56 million in PCVX stocks shares; and BLACKROCK INC., currently with $$739.77 million in PCVX stock with ownership which is approximately 8.3552%.
